Literature DB >> 12514630

Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli.

Tadamichi Sakuma1, Howard Leong-Poi, Nick G Fisher, Norman C Goodman, Sanjiv Kaul.   

Abstract

We tested the hypothesis that when acute coronary occlusion is caused by thrombus, part of the no-reflow phenomenon may result from spontaneous or coronary angioplasty-induced microthromboemboli, and that this phenomenon may be partly or wholly reversible. Accordingly, a thrombus was created in the left anterior descending coronary artery of 6 dogs and was labeled in vivo with (99m)Tc-DMP-444 that binds to the IIb/IIIa platelet receptor. Angioplasty was then performed to obtain thrombolysis in myocardial infarction grade-3 flow. Myocardial contrast echocardiography was performed 15 and 60 minutes after recanalization to define perfusion defect size. (99m)Tc-autoradiography and infarct size (IS) measurement were performed postmortem. An additional 5 dogs with coronary artery ligation followed by reperfusion served as control animals. These dogs also underwent myocardial contrast echocardiography and in vivo labeling with (99m)Tc-DMP-44. (99m)Tc uptake was significantly higher in the reperfused bed in dogs with thrombus compared with control dogs (2.7 +/- 0.9 vs 1.4 +/- 0.3 counts/pixel(-1)/min(-1), P =.01) indicating the presence of microthromboemboli. Perfusion defect size early (15 minutes) after recanalization was smaller than the hot spot on autoradiography and overestimated IS in dogs with thrombus. Perfusion defect size decreased with time and was closer to IS 60 minutes after recanalization. The dogs with thrombi demonstrated larger IS/risk area ratios compared with the 5 control dogs (46 +/- 6% vs 27 +/- 12%, P =.04). We conclude that part of the no-reflow phenomenon seen after angioplasty in acute coronary thrombosis is a result of microthromboemboli and is mostly reversible. No reflow late after reperfusion is a result of tissue necrosis. The thrombus burden also affects ultimate IS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514630     DOI: 10.1067/mje.2003.44

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  22 in total

1.  Spontaneous and interventional coronary microembolisation.

Authors:  R Erbel
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 2.  Thrombectomy during primary angioplasty: methods, devices, and clinical trial data.

Authors:  Giuseppe De Luca; Monica Verdoia; Ettore Cassetti
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

Review 3.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 4.  Intramyocardial haemorrhage after acute myocardial infarction.

Authors:  Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2014-11-18       Impact factor: 32.419

5.  Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarction.

Authors:  Feng Xie; Jeroen Slikkerveer; Shunji Gao; John Lof; Otto Kamp; Evan Unger; Stanley Radio; Terry Matsunaga; Thomas R Porter
Journal:  J Am Soc Echocardiogr       Date:  2011-10-29       Impact factor: 5.251

6.  Efficacy of dual antiplatelet therapy combined with Naoxintong capsules [see text] following coronary microembolization induced by homologous microthrombi in rats.

Authors:  Huan Wang; Wen-juan Zhong; Ming-wei Huang; Xiao-ying Wu; Hui Chen
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

7.  Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES.

Authors:  Giuseppe De Luca; Rosario Sauro; Attilio Varricchio; Michele Capasso; Tonino Lanzillo; Fiore Manganelli; Ciro Mariello; Francesco Siano; Giannignazio Carbone; Maria Rosaria Pagliuca; Giuseppe Rosato; Emilio Di Lorenzo
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

8.  Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.

Authors:  Giuseppe De Luca; C Michael Gibson; Francesco Bellandi; Marko Noc; Mauro Maioli; Simona Zorman; Uwe Zeymer; H Mesquita Gabriel; Ayse Emre; Donald Cutlip; Hans-Richard Arntz; Dariusz Dudek; Tomasz Rakowski; Maryann Gyongyosi; Kurt Huber; Arnoud W J van't Hof
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

9.  Efficacy of Sonothrombolysis Using Microbubbles Produced by a Catheter-Based Microfluidic Device in a Rat Model of Ischemic Stroke.

Authors:  Adam J Dixon; Jun Li; John-Marschner Robert Rickel; Alexander L Klibanov; Zhiyi Zuo; John A Hossack
Journal:  Ann Biomed Eng       Date:  2019-01-28       Impact factor: 3.934

10.  Preprocedural TIMI flow and infarct size in STEMI undergoing primary angioplasty.

Authors:  Giuseppe De Luca; Guido Parodi; Roberto Sciagrà; Francesco Venditti; Benedetta Bellandi; Ruben Vergara; Angela Migliorini; Renato Valenti; David Antoniucci
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.